PAGE 2

- - 9 - 12

-- ( MMR) 2 9-12 1 MMR 1 MMR 9-12 2553 MMR 9 - 12 Vendor Managed Inventory (VMI) 2553 MMR MMR 9-12 1. MMR Jeryl Lynn 9-12 9-12 : MMR 1 9-12 MMR 1 Urabe2. MMR 9-12 2.1 Priorix GlaxoSmithKline (Live attenuated vaccine) 3 2.1.1 Schwarz

2.1.2 RIT 4385 Jeryl Lynn2.1.3 Wistar RA 27/3

2.2 (Lyophilyzed vaccine) 1 1 0.5 . 2.3 (subcutaneous) 2.4 42 12,000 PriorixTM

( 10) 38. 37.5 .

( 1 10) 39.5. 39.

( 0.1 1)

( 0.01 0.1)

Priorix TM * Transverse myelitis anaphylaxis Guillain Barre Syndrome Erythema multiforme Kawassaki syndrome

* 1 10 ( 1 1,000 2,000 1 6,000 )

Priorix TM

2.5 - neomycin (systemic) neomycin (contact dermatitis)

- 3 - primary secondary immunodeficiency MMR HIV HIV

- 2.62.6 - - - (anaphylactic reaction) - chick embryo cell anaphylactic, anaphylactoid anaphylaxis - 2.7 3 (seronegative) 98.0 96.1 99.3

2.8 - 2-8. 6 8 - 3. MMR 18 061